TRADING HALTED

Alpine Immune Sciences Inc ALPN:NASDAQ

RT Quote | USD
Last | 05/17/24 EDT
64.97UNCH (UNCH)
52 week range
8.33 - 65.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close64.97
  • 52 Week High65.00
  • 52 Week High Date05/17/24
  • 52 Week Low8.33
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap4.457B
  • Shares Out68.60M
  • 10 Day Average Volume1.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change240.87

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close64.97
  • 52 Week High65.00
  • 52 Week High Date05/17/24
  • 52 Week Low8.33
  • 52 Week Low Date10/26/23
  • Market Cap4.457B
  • Shares Out68.60M
  • 10 Day Average Volume1.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change240.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-95.03
  • Fwd P/E (NTM)-41.28
  • EBITDA (TTM)-50.771M
  • ROE (TTM)-14.67%
  • Revenue (TTM)56.521M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-65.17%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alpine Immune Sciences Inc

 

Profile

MORE
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which is engaged in discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company’s approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its ALPN-303 (povetacicept) is a dual antagonist of the B cell activating factor (BAFF) and a proliferation, inducing...
Mitchell Gold M.D.
Executive Chairman of the Board, Chief Executive Officer
Stanford Peng M.D., Ph.D.
President, Head - Research and Development
Paul Rickey CPA
Chief Financial Officer, Senior Vice President, Corporate Secretary
Address
188 East Blaine St., Suite 200
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
NUVL
Nuvalent Inc
70.93+0.05+0.07%
KRYS
Krystal Biotech Inc
164.45+0.35+0.21%
MDGL
Madrigal Pharmaceuticals Inc
232.10+12.04+5.47%
CRNX
Crinetics Pharmaceuticals Inc
50.62-0.78-1.52%
CRSP
CRISPR Therapeutics AG
55.47-0.75-1.33%